Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subject Satisfaction with BOTOX Cosmetic in Facial Rhytides
NCT01777620Phase 4Completed
- Sponsor
- Allergan
- Start
- Jan 2013
- Primary completion
- May 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of onabotulinumtoxinA in facial rhytides, sponsored by Allergan. Started Jan 2013; status: completed.
02
Drugs
onabotulinumtoxinA
03
Conditions
facial rhytides
Beyond the preview
Go deeper on NCT01777620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01777620.